Asia‐Pacific Leukemia Consortium: An innovative and collaborative initiative to improve care of leukemia and related diseases in the Asia‐Pacific region
Z Lao, EWC Tse, S Chuncharunee… - Asia‐Pacific Journal …, 2023 - Wiley Online Library
The burden of leukemia and related diseases is rapidly growing in Asia. Currently, there is a
paucity of regional collaborative groups/initiatives that focus exclusively on the management …
paucity of regional collaborative groups/initiatives that focus exclusively on the management …
CD19/CD20 dual-targeted chimeric antigen receptor-engineered natural killer cells exhibit improved cytotoxicity against acute lymphoblastic leukemia
N Yang, C Zhang, Y Zhang, Y Fan, J Zhang… - Journal of Translational …, 2024 - Springer
Background Chimeric antigen receptor natural killer (CAR-NK) cells represent a promising
advancement in CAR cell therapy, addressing limitations observed in CAR-T cell therapy …
advancement in CAR cell therapy, addressing limitations observed in CAR-T cell therapy …
Global incidence and mortality of childhood leukemia and its relationship with the Human Development Index
A Mohammadian-Hafshejani, IM Farber, S Kheiri - Plos one, 2024 - journals.plos.org
Background Childhood leukemia (CL) is a major global concern, accounting for 33% of all
new cancer cases and 31% of all cancer deaths in children aged 0–14 years. Our study …
new cancer cases and 31% of all cancer deaths in children aged 0–14 years. Our study …
Association of markers of inflammation on attention and neurobehavioral outcomes in survivors of childhood acute lymphoblastic leukemia
Background Survivors of childhood acute lymphoblastic leukemia (ALL) are at-risk of
developing cognitive impairment and neurobehavioral symptoms. Inflammation induced by …
developing cognitive impairment and neurobehavioral symptoms. Inflammation induced by …
[HTML][HTML] 嵌合抗原受体T 细胞在儿童复发难治性急性淋巴细胞白血病中的研究进展
韦楠, 陈天平 - Chinese Journal of Contemporary Pediatrics, 2023 - ncbi.nlm.nih.gov
目前儿童复发难治性急性淋巴细胞白血病的治疗仍处于困境, 即使提高化疗强度或联合造血
干细胞移植, 仍有部分患儿预后差, 生存期短。 嵌合抗原受体T 细胞( chimeric antigen …
干细胞移植, 仍有部分患儿预后差, 生存期短。 嵌合抗原受体T 细胞( chimeric antigen …
[PDF][PDF] 儿童高白细胞性急性淋巴细胞白血病的临床特征及预后分析
崔东艳, 徐雨婷, 刘爱国, 张艾, 王雅琴… - 临床血液学 …, 2022 - lcxyen.whuhzzs.com
目的: 分析儿童高白细胞性急性淋巴细胞白血病(ALL) 的临床特征并评估预后. 方法:
回顾性收集2015 年1 月—2020 年6 月诊断的244 例初治ALL 患儿的临床资料, 均按照CCCG …
回顾性收集2015 年1 月—2020 年6 月诊断的244 例初治ALL 患儿的临床资料, 均按照CCCG …
Childhood cancer survivorship in China: An overview of the past two decades
Across countries in the world, China has the largest population of childhood cancer
survivors. Research and care for the childhood cancer survivor population in China is …
survivors. Research and care for the childhood cancer survivor population in China is …
Blinatumomab therapy for B cell acute lymphoblastic leukemia accompanied by persistent or relapsed low-level MRD prior to hematopoietic stem cell transplantation …
G Zhou, L Wang, X Tang, S Liu, T Li, Y Liu… - Bulletin of the National …, 2023 - Springer
Background Blinatumomab could be successfully used to reduce minimal residual disease
(MRD) prior to hematopoietic stem cell transplantation (HSCT) in pediatric B cell precursor …
(MRD) prior to hematopoietic stem cell transplantation (HSCT) in pediatric B cell precursor …
Issues of epidemiology, diagnostics and organization of oncological service in children: literature review.
A Kaliyeva, A Turgambayeva, Z Nakipov, G Dauletova… - 2023 - cabidigitallibrary.org
Introduction. In childhood, malignant neoplasms are quite rare, which leads to insufficient
alertness of doctors in terms of their early diagnosis. This is especially true for general …
alertness of doctors in terms of their early diagnosis. This is especially true for general …
Recent research on chimeric antigen receptor T cells in children with refractory/relapsed acute lymphoblastic leukemia
N Wei, TP Chen - Zhongguo Dang dai er ke za zhi= Chinese …, 2023 - europepmc.org
目前儿童复发难治性急性淋巴细胞白血病的治疗仍处于困境, 即使提高化疗强度或联合造血
干细胞移植, 仍有部分患儿预后差, 生存期短. 嵌合抗原受体 T 细胞 (chimeric antigen receptor T …
干细胞移植, 仍有部分患儿预后差, 生存期短. 嵌合抗原受体 T 细胞 (chimeric antigen receptor T …